Manhattan Institute

Prescription Drugs and Price Controls

10 Blocks Podcast

John Tierney joins City Journal editor Brian Anderson to discuss what the debate over prescription drugs gets wrong and the cost that government-imposed price controls could have on one of the world’s most innovative industries.

The business practices of the pharmaceutical industry—or “Big Pharma”—are one of the most divisive political issues of our time. Leaders from both political parties, from Bernie Sanders to President Trump, regularly denounce drug companies for profiteering and call for lower drug prices. But as Tierney notes in City Journal, “of every dollar that Americans spend on health, only a dime goes for prescription drugs. The lion’s share of health spending goes to hospitals and people in the health-care professions.”

America has been called the “Pharmacy to the World” because it’s where more than half of new drugs get developed and tested in clinical trials. Patients in Europe and elsewhere enjoy the benefits of these breakthrough drugs. Price controls in the U.S. would significantly curtail new research and development projects—resulting in a net loss for everyone.

More from Manhattan Institute

Manhattan Institute2 min read
Beating My Dad
I should have listened more when my dad taught me tennis. Instead, I moped on the courts. My dad, Toby, was the only father out there. This was in the 1960s, in suburban Cleveland. My dad was often shirtless on the courts. A bare-chested guy—wearing
Manhattan Institute4 min readPolitics
The Democrats’ Pennsylvania Edge
Rejecting Donald Trump, voters in Greater Philadelphia pose a major obstacle to Republican chances.
Manhattan Institute5 min read
Justice Thomas’s Credo
One of the most striking aspects of Monday’s Supreme Court decision in Gamble v. United States was Clarence Thomas’s eloquent summary of the core precept of his judicial philosophy: that stare decisis—the venerable doctrine that courts should respect